Drugs Made In America Acquisition II Corp.Drugs Made In America Acquisition II Corp.Drugs Made In America Acquisition II Corp.

Drugs Made In America Acquisition II Corp.

No trades
Previous close
Open
Volume
Dividend yield (indicated)

About Drugs Made In America Acquisition II Corp.


Sector
CEO
Lynn Darlene Stockwell
Headquarters
Fort Lauderdale
Identifiers
3
ISIN KYG2851K1123
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.